Patient 1
Patient 1 (IV-1; figure, A) was born from nonconsanguineous Caucasian parents. Focal dystonia started at age 40 years with painful dystonic writer's cramp affecting the right wrist and finger flexors. She was treated with botulinum toxin injections, but after 10 years, she discontinued treatment because of very mild symptoms. At age 60 years, only increased blink rate was noted. Two of her children were identified with hyperkinetic movements from adolescence (figure, A). A daughter (V-2; figure, A) had an increased blink rate and a mild head tremor. Her son (V-3; figure, A) was treated with botulinum toxin for a dystonic head tremor and mild torticollis. Gene panel sequencing was performed as described previously, 5 revealing a likely pathogenic mutation, c.934A>G; p.R312G in TOR1A (figure, B), which is conserved down to zebrafish (figure, C), has a Combined Annotation Dependent Depletion (cadd.gs.washington. edu) score of 19.5, and is found only once in 246266 alleles (0.0004061%) in the gnomAD database (gnomad.broadinstitute.org). Sanger sequencing revealed segregation of the mutation with the phenotype (figure, A). Using homology modeling, a possible deleterious effect of p.R312G was assessed. 6 The basic torsinA structure should be unaffected by the variant. In the wild type, however, the highly flexible arginine allows R312 to come as close as 2.7 Å to one of the adenosine triphosphate ribose hydroxyls and make hydrogen bonds. In the R312G mutant, this interaction is lost, thus possibly causing protein malfunctioning (figure, D).
Patient 2
Patient 2 (II-1; figure, E) was born from nonconsanguineous Caucasian, healthy parents. Preand postnatal periods and psychomotor development were normal. Dystonia started cervically at age 15 years, with phasic torti-and retrocollis, which within 2 years generalized to involve the trunk and upper extremities. Cervical botulinum toxin injections provided some relief until age 23 years. Oral trihexyphenidyl, and levodopa and clonazepam added 2 years later, improved his severe axial dystonia only slightly. At age 26 years, brain and spine MRI and neuropsychological testing were normal. Testing for the classic 3-basepair deletion in TOR1A was negative. He had no impairment of voice, speech, or swallowing, but pathologic face grimacing and moderate distal extremity dystonia. Since age 27 years, his generalized dystonia has been treated successfully with deep brain stimulation (DBS) of the internal globus pallidus bilaterally, with a marked and sustained effect, allowing medication to be tapered off. At age 42 years, he has residual mild retrocollis and thoracic kyphoscoliotic posture. Gene panel sequencing revealed a previously reported missense mutation, c.863G>A; p.R288Q in TOR1A, 7 with paternal inheritance and reduced penetrance, the latter also witnessed by Zirn et al. 7 (figure, E and F).
Herein, we report a novel TOR1A missense mutation, p.R312G, which segregated with mild isolated segmental dystonia in a small family. Multiple lines of bioinformatic predictions indicate possible deleterious effects on protein function. However, functional analyses and identification of genetic recurrence are warranted to confirm its pathogenicity.
Of the published missense mutations in TOR1A (mdsgene. org), genetic recurrence has so far only been reported for p.
T321M. We report a patient carrying p.R288Q, with adolescent-onset, isolated generalized dystonia and marked axial and little cranial involvement. This mutation was previously reported in a patient with very early childhood-onset lower limb dystonia and severe generalization, who at age 18 years had dysphagia, dysarthria, joint contractures, pyramidal signs, and cerebellar atrophy. 7 Treatment with DBS was not mentioned. Additional experiments strongly indicated pathogenicity of the p.R288Q variant, 7 which is further confirmed by our present finding.
Most reported patients with TOR1A missense mutations presented with adult onset, including the p.R312G index patient in our study. This may indicate that missense mutations have a less profound effect on torsinA function than the common deletion. However, the phenotypic spectrum of TOR1A mutations is very broad, ranging from nonpenetrance to isolated focal, segmental, or generalized dystonia in carriers of different types of mutations, which is highlighted in our and previous reports. 3, 4, 7 The causes of this large phenotypic 
